Prominent Investors Expect High Returns from Longevity Research
A
Aubrey de Grey during the Longevity Investors Conference 2024
Story of claim
Investors like Peter Thiel and Michael Greve have significantly invested in longevity research, anticipating substantial returns.
- Goal: Achieve high returns on investments in longevity research.
- Proof: Significant investments by prominent figures signal confidence in potential returns.
- Nuances:
- Investment linked to past funding
- Influence of private sector figures
- Laura Deming's role noted
- Impact on Life: Increased funding could accelerate research and development in longevity.
Investments
- Price: >$5 million per investor
- Time:
- Effort:
Risks
Investment risks include potential delays in achieving scientific breakthroughs.
Get Started 🚀
- Explore investment opportunities in longevity startups
- Network with prominent figures in the longevity sector
Brogevity AI can make mistakes. Check important info.